Order Article Reprints

Liu C, Cojutti PG, Giannella M, Roberto M, Casadei B, Cristiano G, Papayannidis C, Vianelli N, Zinzani PL, Viale P, et al. Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study. Pharmaceutics. 2023; 15(3):1022. https://doi.org/10.3390/pharmaceutics15031022

Liu, Chun, Pier Giorgio Cojutti, Maddalena Giannella, Marcello Roberto, Beatrice Casadei, Gianluca Cristiano, Cristina Papayannidis, Nicola Vianelli, Pier Luigi Zinzani, Pierluigi Viale, and et al. 2023. "Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study" Pharmaceutics 15, no. 3: 1022. https://doi.org/10.3390/pharmaceutics15031022

Liu, C., Cojutti, P. G., Giannella, M., Roberto, M., Casadei, B., Cristiano, G., Papayannidis, C., Vianelli, N., Zinzani, P. L., Viale, P., Bonifazi, F., & Pea, F. (2023). Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study. Pharmaceutics, 15(3), 1022. https://doi.org/10.3390/pharmaceutics15031022